Fig. 3. Pax2-/-; Pax6+/- eyes show
transdifferentiation of the RPE into a second, inverted NR and reduced Mitf
expression. Hematoxylin-Eosin (A,B,D,E,G,H) and immunohistochemical staining
of serial, 6 µm sections using an antibody against the retinal ganglion
cell marker Brn3b (C,F,I) and the RPE determinant Mitf (J-P). At E18.5, the
wild-type eye differentiated to laminated NR, RPE and lens (A,B). The
Pax2-/-; Pax6+/- eye did not
form a lens, but the NR was much more expanded and folded at the expense of
RPE development (D; detailed view in E). By contrast, at the same stage the
Pax2-/- mutant eye displays a fully developed optic cup
but the NR and the RPE are expanded towards the optic stalk (G,H). The
expression of Brn3b in retinal ganglion cells marked the innermost layer of
the NR in wild-type (arrow, C) and Pax2-/- NR (I). In the
Pax2-/-; Pax6+/- eye, Brn3b expression
(arrows) is confined to the inner layer of the inner NR (F: 1. nr) and to the
outermost cell layer in the outer NR (F: 2. nr), indicating that the second NR
is inverted compared to the inner NR. (J-P) At E9.5, Mitf expression is
detected in the wild-type (J) and Pax2-/-;
Pax6+/- OVs (M), predominantly in the proximal region. At
E10.5, Mitf activity is confined to the outer layer of the optic cup in wild
type (K, ol), but starts to be downregulated in the folded distal inner layer
regions of Pax2-/-; Pax6+/- eyes (N,
il). Mitf is still expressed the forming RPE in the wild-type E11.5 eye (L),
whereas in the Pax2-/-; Pax6+/- optic
cup, it is only found in regions between the newly formed, folded, NR regions
and in the proximal RPE remnant (O, arrows). In the
lens-CRE/Pax6flx/flx eye, Mitf-positive RPE surrounds the
folded NRs, similar to wild-type RPE (P).